 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Nomination and Remuneration / Compensation Committee of Aurobindo Pharma Ltd on March 09, 2017 has allotted 6,97,823 equity shares of Re. 1/- each under ESOP Scheme of the Company. Consequent to the allotment, the paid up share capital of the Company has increased from 58,51,69,586 Equity Shares of Re. 1/- each to 58,58,67,409 Equity Shares of Re. 1/- each.
Shares of AUROBINDO PHARMA LTD. was last trading in BSE at Rs.658.25 as compared to the previous close of Rs. 666.05. The total number of shares traded during the day was 123065 in over 4196 trades.
The stock hit an intraday high of Rs. 667.1 and intraday low of 655. The net turnover during the day was Rs. 81316747.